Results 51 to 60 of about 14,471,607 (152)

Borderline Resectable Classification Identifies Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab

Hepatology Research, Volume 56, Issue 5, Page 830-839, May 2026.
ABSTRACT Background Conversion therapy, which seeks to achieve curative treatment following systemic therapy, is increasingly acknowledged in the management of unresectable hepatocellular carcinoma (HCC). However, validated criteria for predicting eligibility for conversion remain unclear. We investigated the utility of the recently proposed borderline
Yasuto Takeuchi, Masahiko Sue, Nozomi Miyake, Takuya Adachi, Hideki Onishi, Miwa Kawanaka, Akinobu Takaki, Kazuhiro Nouso, Kazuya Kariyama, Shinichiro Nakamura, Emi Tanaka, Toshifumi Tada, Tetsuya Yasunaka, Kenji Kuwaki, Junichi Toshimori, Shota Iwado, Akio Moriya, Hiroaki Hagihara, Hiroyuki Takabatake, Masahiro Sakata, Motoyuki Otsuka   +20 more
wiley   +1 more source

Des-gamma-carboxyprothrombin: clinical effectiveness and biochemical importance.

Bioscience trends, 2010
Des-gamma-carboxyprothrombin (DCP) is an abnormal prothrombin with a decreased number of gamma-carboxylated glutamic acid residues in the Gla domain. DCP is also known to be an effective serological tumor marker for hepatocellular carcinoma (HCC), and highly sensitive methods of detecting serum DCP have enabled the detection of early and smallsized HCC
Yoshinori, Inagaki, Wei, Tang, Huanli, Xu, Fengshan, Wang, Munehiro, Nakata, Yasuhiko, Sugawara, Norihiro, Kokudo   +6 more
openaire   +1 more source

Cover Jurnal Gamma Vol. 10 No.1, September 2015

, 2015
Cover Jurnal Gamma Vol.
., Cover
core   +1 more source

Liquid biopsy biomarkers for early detection of gastrointestinal cancers: Current landscape and emerging technologies

Clinical and Translational Medicine, Volume 16, Issue 3, March 2026.
This narrative review provides a comprehensive overview of liquid biopsy biomarkers for early detection of gastrointestinal cancers focusing on technological innovations, clinical performance and ongoing clinical trials. Abstract Early detection of gastrointestinal (GI) cancers remains a critical unmet clinical need, as most patients are diagnosed at ...
Muhammad Anees, Christopher Sherry, Hyun Y. Park, Erin E. Grayhack, Arul Goel, Alisha F. Khan, Ashten Omstead, David L. Bartlett, Ajay Goel, Neda Dadgar, Patrick L. Wagner, Ali H. Zaidi   +11 more
wiley   +1 more source

Cover Jurnal Gamma Vol.9, No.2, Maret 2014

, 2015
Cover Jurnal Gamma Vol.9, No.2, Maret ...
., Cover
core   +1 more source

Screening for Hepatocellular Carcinoma Recurrence After Liver Transplantation: Prospective Validation of Binary Criteria

Cancer Medicine, Volume 14, Issue 23, December 2025.
ABSTRACT Background Many centers screen all recipients for hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT). This approach may add substantial burdens of cost, incidental findings, and, depending on the imaging modality, radiation and/or contrast‐induced complications. We created simple criteria to help clinicians identify low‐
Wesley Dixon, Shaun Chandna, Jordan S. Sack, Meagan Gray, Christina N. Brown, Sampath Poreddy, Kai Ha, Michael R. Schoech, Stephen D. Zucker   +8 more
wiley   +1 more source

A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced Stage

Cancer Medicine, Volume 14, Issue 20, October 2025.
ABSTRACT The variety of treatments available makes it difficult to determine whether a treatment would be effective for an individual case in advanced‐stage hepatocellular carcinoma. We aimed to establish a new model of survival prediction in patients to establish standards in the recent and coming multimolecular targeted agents era.
Masashi Ninomiya, Mio Tsuruoka, Jun Inoue, Atsushi Hiraoka, Akitoshi Sano, Kosuke Sato, Masazumi Onuki, Satoko Sawahashi, Keishi Ouchi, Kengo Watanabe, Hidekatsu Kuroda, Takayoshi Oikawa, Tamami Abe, Masashi Fujita, Kazumichi Abe, Tomohiro Katsumi, Wataru Sato, Go Igarashi, Chikara Iino, Nobukazu Tanabe, Hiroshi Numao, Hiromasa Ohira, Yoshiyuki Ueno, Atsushi Masamune   +23 more
wiley   +1 more source

Cover Jurnal Gamma, Vol. 8, No.1, September 2012

, 2014
Cover Jurnal Gamma, Vol.
., Cover
core   +1 more source

FIB‐3 index as a novel age‐independent predictor of liver fibrosis and prognosis in hepatocellular carcinoma patients undergoing hepatectomy

Annals of Gastroenterological Surgery, Volume 9, Issue 5, Page 1055-1065, September 2025.
Fibrosis‐3 index (FIB‐3) can stratify the risk of the survival and the recurrence‐free survival. The FIB‐3 index is a reliable, age‐independent tool for assessing liver fibrosis and prognosis in HCC patients post‐hepatectomy. Its use may improve clinical outcomes and support personalized treatment strategies. Abstract Background Liver fibrosis is a key
Yuki Imaoka, Masahiro Ohira, Tsuyoshi Kobayashi, Naruhiko Honmyo, Michinori Hamaoka, Takashi Onoe, Daisuke Takei, Koichi Oishi, Tomoyuki Abe, Toshihiro Nakayama, Miho Akabane, Kazunari Sasaki, Hideki Ohdan, Hiroshima Surgical study group of Clinical Oncology (HiSCO)   +13 more
wiley   +1 more source

Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K-1) in severe acute liver disease [PDF]

, 2005
Background/Aims: In patients with severe acute liver dysfunction, i.v. phylloquinone (vitamin K-1) may be given to exclude vitamin K deficiency, rather than impaired hepatic synthesis of coagulation factors alone, as the cause of the coagulopathy ...
Pereira, SP, David Rowbotham, Stephen P. Pereira, Sarah Fitt, Fitt, S, Pereira, S P, Wendon, J, Roger Williams, Williams, R, Julia Wendon, Rowbotham, D, Martin J. Shearer, Shearer, MJ, Shearer, M J   +13 more
core   +1 more source